Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

Genetic an environmental factorscausingvariability in psychotropic drug response

many factorscan ... contributeto variability in drug response

Genetics ... the factorscontributeto variability in drug response

quantify factorsinfluencesvariability in drug response

Clinical , environmental , and genetic factorscontributeto variability in drug response

genetic and non - genetic factorscontributeto variability in drug response

1985 Pharmacokinetic factorsinfluencingvariability in human drug response

B. " Pharmacokinetic factorsinfluencingvariability in human drug response

the identification of genomic factorsinfluencingvariability in drug response

198139:5 - 14 pharmacokinetic factorsinfluencingvariability in human drug response

how individual gene variationscausevariability in drug responses

other potential patient - related factors such as age , smoking behaviour , renal and liver functioncould ... contributeto the variability in drug response

the genes and mutations in these genescausingvariation in drug response

Recent PGx investigations ... genesmight causedrug response variability

how genetic ( genome ) differences in MULTIPLE genesinfluencevariability in drug response

genetic variation in any of the genes regulating this pathwaymay causevariation in drug response

4 Plasma Binding Proteins Several physiological or pathological conditions including renal failure , cirrhosis , and inflammatory states , can modify the circulating level of goлd binding good trading strategy forex teins , mainly serum albumin and a1-acid glycoproteinresultingin drug response variability

best spot forex broker circumstances in whichwill contributeto variability in drug response

Variations in genes involved in drug disposition and in eliciting drug responsesignificantly contributeto the interpatient variability in drug response

variations in molecular function conferred by polymorphisms ( and mutations ) in one or more genes modulating drug actionscausevariability in drug response

specific genes and gene products associated with various Identifying genes and allelic variants of genesleadsto variability in drug response

besides genetic variation in genes encoding enzymes / proteins and transporters involved in the pharmacokinetics and pharmacodynamics ( pharmacogeneticscontributeto variability of drug response

Pharmacogenomic variants are knownto influencevariation in drug response

The activity level of these enzymes varies from one person to the nextleadingto variability in drug response

genomic heterogeneityleadsto variability in drug responses

knowledge about genetic differences , or polymorphismscontributeto variability in drug responses

Molecular mechanismscontributingto variability in drug response

An important aspectcontributesto variability in drug response

Interindividual differences in drug transporter expressioncan resultin variability in drug response

This ‘ one - dose - fits - all ’ approachleadsto variability in drug response

the drug metabolismleadingto variability in drug response

This could be different in different strains of Leishmania , as well as in different infected individuals ,leadingto variability in drug response

assumedto causedrug response variability

Information regarding patient characteristics ( e.g. , age , ethnicity , renal / hepatic function , concomitant disease , etc . ) knownto contributeto variability in drug response

Because every tumor exhibits a unique constellation of genomic alterations , regardless of the tissue of origin , and genomiccan leadto variability in drug responses

CYP ) enzyme systemcontributeto variability in drug response

key genetic variantsinfluencingvariation in drug response

genetic variabilitycontributesto the variability in drug response

the processescontributingto variability in drug response

to therapeutic failure ( eg , ultrarapid metabolizers ) and adverse drug responses ( poor metabolizerscan leadto therapeutic failure ( eg , ultrarapid metabolizers ) and adverse drug responses ( poor metabolizers

to therapeutic failure ( eg , ultrarapid metabolizers ) and adverse drug responses ( poor metaboliz- erscan leadto therapeutic failure ( eg , ultrarapid metabolizers ) and adverse drug responses ( poor metaboliz- ers

both efficacy and safetymay influenceboth efficacy and safety

to variation in drug safety and efficacyleadsto variation in drug safety and efficacy

in differences in clinical efficacymay resultin differences in clinical efficacy

partly from geneticsoriginatespartly from genetics

largely from genetically determined differences in 89 % of serum sicknessmay resultlargely from genetically determined differences in 89 % of serum sickness

the economic and societal burden(passive) caused bythe economic and societal burden

treatment failurecausestreatment failure

in very serious nega - tive consequencescan resultin very serious nega - tive consequences

Blob

Smart Reasoning:

C&E

See more*